-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74 108 (Pubitemid 40372904)
-
(2005)
Ca-A Cancer Journal for Clinicians
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
3
-
-
38349179764
-
Early detection of ovarian cancer: New technologies in pursuit of a disease that is neither common nor rare
-
discussion 47-48
-
R.C. Bast Jr. Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare Trans Am Clin Climatol Assoc 115 2004 233 247 discussion 47-48
-
(2004)
Trans Am Clin Climatol Assoc
, vol.115
, pp. 233-247
-
-
Bast, Jr.R.C.1
-
4
-
-
38149025644
-
Discovery and application of protein biomarkers for ovarian cancer
-
A. Gagnon, and B. Ye Discovery and application of protein biomarkers for ovarian cancer Curr Opin Obstet Gynecol 20 2008 9 13
-
(2008)
Curr Opin Obstet Gynecol
, vol.20
, pp. 9-13
-
-
Gagnon, A.1
Ye, B.2
-
5
-
-
56449084421
-
Hereditary ovarian cancer
-
A. Russo, V. Calo, L. Bruno, S. Rizzo, V. Bazan, and G. Di Fede Hereditary ovarian cancer Crit Rev Oncol Hematol 69 2009 28 44
-
(2009)
Crit Rev Oncol Hematol
, vol.69
, pp. 28-44
-
-
Russo, A.1
Calo, V.2
Bruno, L.3
Rizzo, S.4
Bazan, V.5
Di Fede, G.6
-
6
-
-
23944476784
-
Hereditary ovarian cancer
-
DOI 10.1016/j.humpath.2005.06.006, PII S0046817705002832
-
J. Prat, A. Ribe, and A. Gallardo Hereditary ovarian cancer Hum Pathol 36 2005 861 870 (Pubitemid 41187904)
-
(2005)
Human Pathology
, vol.36
, Issue.8
, pp. 861-870
-
-
Prat, J.1
Ribe, A.2
Gallardo, A.3
-
7
-
-
4644271551
-
Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients
-
DOI 10.1158/0008-5472.CAN-04-1529
-
I. Ibanez de Caceres, C. Battagli, and M. Esteller Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients Cancer Res 64 2004 6476 6481 (Pubitemid 39297903)
-
(2004)
Cancer Research
, vol.64
, Issue.18
, pp. 6476-6481
-
-
De Caceres, I.I.1
Battagli, C.2
Esteller, M.3
Herman, J.G.4
Dulaimi, E.5
Edelson, M.I.6
Bergman, C.7
Ehya, H.8
Eisenberg, B.L.9
Cairns, P.10
-
9
-
-
22244433142
-
Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression
-
DOI 10.1158/1055-9965.EPI-04-0704
-
D.G. Peters, D.M. Kudla, and J.A. Deloia Comparative gene expression analysis of ovarian carcinoma and normal ovarian epithelium by serial analysis of gene expression Cancer Epidemiol Biomarkers Prev 14 2005 1717 1723 (Pubitemid 40995085)
-
(2005)
Cancer Epidemiology Biomarkers and Prevention
, vol.14
, Issue.7
, pp. 1717-1723
-
-
Peters, D.G.1
Kudla, D.M.2
DeLoia, J.A.3
Chu, T.J.4
Fairfull, L.5
Edwards, R.P.6
Ferrell, R.E.7
-
10
-
-
77955822375
-
Proteomics and biomarkers for ovarian cancer diagnosis
-
B. Zhang, Z. Barekati, and C. Kohler Proteomics and biomarkers for ovarian cancer diagnosis Ann Clin Lab Sci 40 2010 218 225
-
(2010)
Ann Clin Lab Sci
, vol.40
, pp. 218-225
-
-
Zhang, B.1
Barekati, Z.2
Kohler, C.3
-
11
-
-
21244460388
-
Proteomics: The next revolution in laboratory medicine?
-
DOI 10.1016/j.cccn.2005.03.017, PII S0009898105001889, Clinical Proteomics: Translation of New Insights into Clinical Practice
-
M. Plebani Proteomics: the next revolution in laboratory medicine? Clin Chim Acta 357 2005 113 122 (Pubitemid 40894636)
-
(2005)
Clinica Chimica Acta
, vol.357
, Issue.2
, pp. 113-122
-
-
Plebani, M.1
-
12
-
-
0037116832
-
Use of proteomic patterns in serum to identify ovarian cancer
-
DOI 10.1016/S0140-6736(02)07746-2
-
E.F. Petricoin, A.M. Ardekani, and B.A. Hitt Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572 577 (Pubitemid 34178440)
-
(2002)
Lancet
, vol.359
, Issue.9306
, pp. 572-577
-
-
Petricoin III, E.F.1
Ardekani, A.M.2
Hitt, B.A.3
Levine, P.J.4
Fusaro, V.A.5
Steinberg, S.M.6
Mills, G.B.7
Simone, C.8
Fishman, D.A.9
Kohn, E.C.10
Liotta, L.A.11
-
13
-
-
4143067096
-
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
-
DOI 10.1158/0008-5472.CAN-04-0746
-
Z. Zhang, R.C. Bast Jr., and Y. Yu Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res 64 2004 5882 5890 (Pubitemid 39095590)
-
(2004)
Cancer Research
, vol.64
, Issue.16
, pp. 5882-5890
-
-
Zhang, Z.1
Bast Jr., R.C.2
Yu, Y.3
Li, J.4
Sokoll, L.J.5
Rai, A.J.6
Rosenzweig, J.M.7
Cameron, B.8
Wang, Y.Y.9
Meng, X.-Y.10
Berchuck, A.11
Van Haaften-Day, C.12
Hacker, N.F.13
De Bruijn, H.W.A.14
Van Der Zee, A.G.J.15
Jacobs, I.J.16
Fung, E.T.17
Chan, D.W.18
-
14
-
-
28444458895
-
Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer
-
DOI 10.1002/pmic.200401321
-
N. Ahmed, K.T. Oliva, and G. Barker Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer Proteomics 5 2005 4625 4636 (Pubitemid 41739939)
-
(2005)
Proteomics
, vol.5
, Issue.17
, pp. 4625-4636
-
-
Ahmed, N.1
Oliva, K.T.2
Barker, G.3
Hoffmann, P.4
Reeve, S.5
Smith, I.A.6
Quinn, M.A.7
Rice, G.E.8
-
16
-
-
77955424794
-
Current clinical use of biomarkers for epithelial ovarian cancer
-
R.G. Moore, and S. Maclaughlan Current clinical use of biomarkers for epithelial ovarian cancer Curr Opin Oncol 22 2010 492 497
-
(2010)
Curr Opin Oncol
, vol.22
, pp. 492-497
-
-
Moore, R.G.1
MacLaughlan, S.2
-
17
-
-
20444460289
-
MicroRNA expression profiles classify human cancers
-
DOI 10.1038/nature03702
-
J. Lu, G. Getz, and E.A. Miska MicroRNA expression profiles classify human cancers Nature 435 2005 834 838 (Pubitemid 40839735)
-
(2005)
Nature
, vol.435
, Issue.7043
, pp. 834-838
-
-
Lu, J.1
Getz, G.2
Miska, E.A.3
Alvarez-Saavedra, E.4
Lamb, J.5
Peck, D.6
Sweet-Cordero, A.7
Ebert, B.L.8
Mak, R.H.9
Ferrando, A.A.10
Downing, J.R.11
Jacks, T.12
Horvitz, H.R.13
Golub, T.R.14
-
18
-
-
34548746977
-
MicroRNA signatures in human ovarian cancer
-
DOI 10.1158/0008-5472.CAN-07-1936
-
M.V. Iorio, R. Visone, and G. Di Leva MicroRNA signatures in human ovarian cancer Cancer Res 67 2007 8699 8707 (Pubitemid 47437445)
-
(2007)
Cancer Research
, vol.67
, Issue.18
, pp. 8699-8707
-
-
Iorio, M.V.1
Visone, R.2
Di Leva, G.3
Donati, V.4
Petrocca, F.5
Casalini, P.6
Taccioli, C.7
Volinia, S.8
Liu, C.-G.9
Alder, H.10
Calin, G.A.11
Menard, S.12
Croce, C.M.13
-
19
-
-
45449093192
-
MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
-
DOI 10.1016/j.ygyno.2008.04.033, PII S0090825808003430
-
D.D. Taylor, and C. Gercel-Taylor MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer Gynecol Oncol 110 2008 13 21 (Pubitemid 351853251)
-
(2008)
Gynecologic Oncology
, vol.110
, Issue.1
, pp. 13-21
-
-
Taylor, D.D.1
Gercel-Taylor, C.2
-
20
-
-
57649091633
-
The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
-
K.E. Resnick, H. Alder, J.P. Hagan, D.L. Richardson, C.M. Croce, and D.E. Cohn The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform Gynecol Oncol 112 2009 55 59
-
(2009)
Gynecol Oncol
, vol.112
, pp. 55-59
-
-
Resnick, K.E.1
Alder, H.2
Hagan, J.P.3
Richardson, D.L.4
Croce, C.M.5
Cohn, D.E.6
-
21
-
-
59449097019
-
Clinical applications of metabolomics in oncology: A review
-
J.L. Spratlin, N.J. Serkova, and S.G. Eckhardt Clinical applications of metabolomics in oncology: a review Clin Cancer Res 15 2009 431 440
-
(2009)
Clin Cancer Res
, vol.15
, pp. 431-440
-
-
Spratlin, J.L.1
Serkova, N.J.2
Eckhardt, S.G.3
-
22
-
-
19944426814
-
1 H-NMR-based metabonomics
-
DOI 10.1002/ijc.20651
-
1 H NMR-based metabonomics Int J Cancer 113 2005 782 788 (Pubitemid 40101260)
-
(2005)
International Journal of Cancer
, vol.113
, Issue.5
, pp. 782-788
-
-
Odunsi, K.1
Wollman, R.M.2
Ambrosone, C.B.3
Hutson, A.4
McCann, S.E.5
Tammela, J.6
Geisler, J.P.7
Miller, G.8
Sellers, T.9
Cliby, W.10
Qian, F.11
Keitz, B.12
Intengan, M.13
Lele, S.14
Alderfer, J.L.15
-
23
-
-
33845314350
-
Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors
-
DOI 10.1158/0008-5472.CAN-06-0755
-
C. Denkert, J. Budczies, and T. Kind Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors Cancer Res 66 2006 10795 10804 (Pubitemid 44876975)
-
(2006)
Cancer Research
, vol.66
, Issue.22
, pp. 10795-10804
-
-
Denkert, C.1
Budczies, J.2
Kind, T.3
Weichert, W.4
Tablack, P.5
Sehouli, J.6
Niesporek, S.7
Konsgen, D.8
Dietel, M.9
Fiehn, O.10
-
24
-
-
33845647146
-
Multiple biomarker panels for early detection of ovarian cancer
-
DOI 10.2217/14796694.2.6.733
-
Z.R. Yurkovetsky, F.Y. Linkov, D. E.M., and A.E. Lokshin Multiple biomarker panels for early detection of ovarian cancer Future Oncol 2 2006 733 741 (Pubitemid 44941991)
-
(2006)
Future Oncology
, vol.2
, Issue.6
, pp. 733-741
-
-
Yurkovetsky, Z.R.1
Linkov, F.Y.2
Malehorn, D.E.3
Lokshin, A.E.4
-
25
-
-
64649105107
-
Development and validation of a protein-based signature for the detection of ovarian cancer
-
K. Kim, I. Visintin, A.B. Alvero, and G. Mor Development and validation of a protein-based signature for the detection of ovarian cancer Clin Lab Med 29 2009 47 55
-
(2009)
Clin Lab Med
, vol.29
, pp. 47-55
-
-
Kim, K.1
Visintin, I.2
Alvero, A.B.3
Mor, G.4
|